Physician-initiated first-in-human clinical study using a novel angiogenic peptide, AG30/5C, for patients with severe limb ulcers.
Nakagami H, Yamaoka T, Hayashi M, Tanemura A, Takeya Y, Kurinami H, Sugimoto K, Nakamura A, Tomono K, Tamai K, Katayama I, Rakugi H, Kaneda Y.
Nakagami H, et al. Among authors: tanemura a.
Geriatr Gerontol Int. 2017 Nov;17(11):2150-2156. doi: 10.1111/ggi.13051. Epub 2017 May 10.
Geriatr Gerontol Int. 2017.
PMID: 28488306
Clinical Trial.